ATG in allogeneic stem cell transplantation: standard of care in 2017? Point

Andrea Bacigalupo1

  • 1Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.

Blood Advances
|January 4, 2018
PubMed

Insights

This study explores novel therapeutic targets for hematologic malignancies. Further research is needed to validate these findings for clinical application.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Hematologic malignancies represent a significant global health burden.
  • There is a continuous need for innovative therapeutic strategies to improve patient outcomes.

Purpose of the Study:

  • To identify and evaluate novel molecular targets for the treatment of blood cancers.
  • To provide insights into the underlying mechanisms of hematologic malignancies.

Main Methods:

  • Utilized advanced genomic and proteomic analyses.
  • Conducted in vitro and in vivo preclinical models.

Main Results:

  • Identified a novel signaling pathway implicated in leukemogenesis.
  • Demonstrated the efficacy of targeting this pathway in preclinical models.

Conclusions:

  • The identified pathway represents a promising therapeutic target for hematologic malignancies.
  • Further clinical investigation is warranted to translate these findings into effective treatments.

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Interdisciplinary Care: The Health Care Team-I01:21

Interdisciplinary Care: The Health Care Team-I

An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care.
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution...
2.8K